JPRN-UMIN000008881已完成未知
Plasma levels of active glucagon-like peptide-1 and coronary artery disease - Plasma levels of active GLP-1 and CAD
Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University0 个研究点目标入组 500 人开始时间: 2012年9月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe valvular disease cardiomyopathy significant inflamatory disease neoplasms trauma current use of incretin related drugs unstable condition
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate the effect of a licensed drug to lower blood glucose, liraglutide, on inflammation in patients with diabetic kidney disease.EUCTR2012-005482-12-IEniversity College Dublin
已完成
不适用
Plasma glucagon-like peptide (GLP) (7-36) amide response to low versus high glycaemic index drinks in Type II diabetic subjects and non-diabetic controls.DiabetesISRCTN41341840Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)24
招募中
2 期
The Effect of Prolonged Glucagon-like Peptide 1 Infusion on Gastric Emptying in Healthy VolunteersHyperglycaemiaCritical Illness Induced HyperglycaemiaMetabolic and Endocrine - DiabetesDiabetesACTRN12612001035819Mahesh Umapathysivam10
已完成
不适用
Effects of Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) on insulin secretion and energy balance in human obesity and diabetesutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineDiabetesISRCTN19339824Record Provided by the NHSTCT Register - 2006 Update - Department of Health6
已完成
2 期
Effects of Glucagon-Like Peptide-1 (GLP-1) administration on gastric emptying during periods of hyperglycaemia in healthy volunteers.Glycaemic control and gastric emptyingMetabolic and Endocrine - Other metabolic disordersACTRN12613001384741Dr Mark Plummer15